US News & World Report – Genetic Tests Predict Response to Warfarin
Variations of a gene that determines a person’s sensitivity to warfarin are important in determining the initial doses of the anti-clotting drug, researchers report.
Related Posts
-
Two Arizona leaders in scientific collaboration partner to advance global TB research -
Critical Path Institute and TGen Forge Partnership to Advance TB Research -
Removing the Bottleneck in Whole Genome Sequencing of Mycobacterium Tuberculosis for Rapid Drug Resistance Analysis: A Call to Action -
A Collaborative Approach for “ReSeq-Ing” Mycobacterium Tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers
-
Integration of Published Information into a Resistance-Associated Mutation Database for Mycobacterium Tuberculosis